Literature DB >> 29242983

[Stressed country doctor with acute visual loss : Clear diagnosis?]

D Heinrich1, M Ulbig2, N Feucht2, M Maier2.   

Abstract

Entities:  

Mesh:

Year:  2018        PMID: 29242983     DOI: 10.1007/s00347-017-0635-3

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


× No keyword cloud information.
  5 in total

1.  EVEREST study: efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathy.

Authors:  Adrian Koh; Won Ki Lee; Lee-Jen Chen; Shih-Jen Chen; Yehia Hashad; Hakyoung Kim; Timothy Y Lai; Stefan Pilz; Paisan Ruamviboonsuk; Erika Tokaji; Annemarie Weisberger; Tock H Lim
Journal:  Retina       Date:  2012-09       Impact factor: 4.256

2.  Polypoidal choroidal vasculopathy: evidence-based guidelines for clinical diagnosis and treatment.

Authors:  Adrian H C Koh; Lee-Jen Chen; Shih-Jen Chen; Youxin Chen; Anantharam Giridhar; Tomohiro Iida; Hakyoung Kim; Timothy Yuk Yau Lai; Won Ki Lee; Xiaoxin Li; Tock Han Lim; Paisan Ruamviboonsuk; Tarun Sharma; Shibo Tang; Mitsuko Yuzawa
Journal:  Retina       Date:  2013-04       Impact factor: 4.256

3.  Idiopathic polypoidal choroidal vasculopathy (IPCV).

Authors:  L A Yannuzzi; J Sorenson; R F Spaide; B Lipson
Journal:  Retina       Date:  1990       Impact factor: 4.256

Review 4.  Photodynamic therapy: current role in the treatment of chorioretinal conditions.

Authors:  D K Newman
Journal:  Eye (Lond)       Date:  2016-01-08       Impact factor: 3.775

5.  Polypoidal Choroidal Vasculopathy.

Authors:  Joon-Bom Kim; Rajinder S Nirwan; Ajay E Kuriyan
Journal:  Curr Ophthalmol Rep       Date:  2017-04-21
  5 in total
  1 in total

1.  [Large macular hole-Always a poor prognosis?]

Authors:  J Friedrich; N Bleidißel; J Klaas; N Feucht; A Nasseri; C P Lohmann; M Maier
Journal:  Ophthalmologe       Date:  2021-03       Impact factor: 1.059

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.